We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Dr. Sam Clark will be presenting about novel salts and polymorphs of psilocybin at this Technology Networks webinar

Breakthroughs in Psychedelic Chemistry: Discovering the World’s First Novel Salts and Polymorphs of Psilocybin, MDMA, LSD and Other Psychedelic Compounds

In this webinar we will explore novel salts and polymorphs of psychedelic substances, including Dr. Sam Clark's discovery of the first new salts and polymorphs of psilocybin, MDMA, LSD, Methylone and other compounds. The importance of salts and polymorphs for novel therapeutics will also be discussed as well as the process of discovery, identification and characterization. Finally, we will discuss the criteria involved in choosing the salts and polymorphs that are most suitable for development into pharmaceutical formulations and their therapeutic applications for patients with neuropsychiatric conditions.

Attend this webinar to discover:

  • New forms of psilocybin, MDMA, LSD and more
  • Why salts and polymorphs are crucial for developing innovative therapeutics in neuropsychiatric conditions
  • The criteria used to select salts and polymorphs for pharmaceutical development, enhancing therapeutic applications for patients
Sam Clark, MD, PhD
Sam Clark, MD, PhD
CEO and Founder
Terran Biosciences
Now Available on Demand!
Information you provide will be shared with the sponsors for this content. Technology Networks or its sponsors may contact you to offer you content or products based on your interest in this topic. You may opt-out at any time.
Want to invite a colleague?

Click the button below to begin inviting a colleague to this Webinar